MYX 0.28% $7.24 mayne pharma group limited

There’s no question ocf will improve. It has to. But the...

  1. 5,389 Posts.
    lightbulb Created with Sketch. 290
    There’s no question ocf will improve. It has to. But the question is by how much and how quickly. When myx acquired the Teva portfolio they certainly didn’t foresee the margin crunch that is taking place.

    Net ocf after interest, working capital and one off items to me is not the ocf. How often do we see one off integration and acquisition costs run into a second year.

    My whole point here is that how can one model the future cash flow of this business with such uncertainty and therefore how can we say this is ‘cheap’. My second point was that relying on the director purchases is fraught with danger for two obvious reasons. Firstly if you’d followed them previously from their large purchases over 1.20, then you’re down 50%, and secondly when you look at the non-recourse loan structure for directors, they are buying on different terms to us.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$7.24
Change
0.020(0.28%)
Mkt cap ! $615.9M
Open High Low Value Volume
$7.30 $7.32 $7.10 $1.066M 147.5K

Buyers (Bids)

No. Vol. Price($)
1 169 $7.17
 

Sellers (Offers)

Price($) Vol. No.
$7.24 3916 2
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
$7.23
  Change
0.020 ( 0.47 %)
Open High Low Volume
$7.23 $7.33 $7.11 37253
Last updated 15.59pm 28/03/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.